USP7 and breast cancer: And in triple-negative BC (TNBC), the special BC type that is currently approved for immunotherapy, USP7 inhibitor GNE-6776 successfully caused apoptosis, inhibited metastasis and remarkably elevated the chemo-sensitivity by disrupting the interaction between USP7 and ABCB1 (Fig. 1E) [90].